Edition:
United Kingdom

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.41USD
15 Dec 2017
Change (% chg)

$0.03 (+9.22%)
Prev Close
$0.38
Open
$0.37
Day's High
$0.42
Day's Low
$0.37
Volume
72,639
Avg. Vol
51,400
52-wk High
$2.85
52-wk Low
$0.36

Chart for

About

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including... (more)

Overall

Beta: -0.12
Market Cap(Mil.): $7.70
Shares Outstanding(Mil.): 8.90
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Akers Biosciences - Accutest Solutions secured new channel partner for sales​

* Akers Biosciences - ‍announces Accutest Solutions a distributor of Akers Bio's breathscan alcohol detector in UK, secured new channel partner for sales​

14 Nov 2017

BRIEF-Akers Biosciences Inc Q2 revenue up 25 pct

* Qtrly loss before income tax reduced by 34% to $666,647 Source text for Eikon: Further company coverage:

15 Aug 2017

BRIEF-Akers Biosciences Q2 revenue $1.2 million

* Q2 revenue $1.2 million Source text for Eikon: Further company coverage:

03 Aug 2017

Earnings vs. Estimates